Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cel-Sci Corporation Common Stock (NY: CVM )

0.7060 +0.0060 (+0.86%)
Streaming Delayed Price Updated: 10:40 AM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cel-Sci Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >
Jim Cramer Prefers This Stock Over Mogo, Considers Endeavor Group As Inexpensive
On CNBC’s "Mad Money Lightning Ro... 
Via Benzinga
CEL-SCI Corporation (NYSE:CVM) Investor Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 09/07/2021 -- Certain directors of CEL-SCI Corporation are under investigation over potential breaches of fiduciary duties. 
Via SBWire
Mid-Day Market Update: monday.com Jumps Following Strong Q2 Results; Kubient Shares Plunge
Midway through trading Tuesday, the Dow traded down 0.81% to 35,336.88 while the NASDAQ fell 0.89% to 14,661.86. The S&P also fell, dropping 0.65% to 4,450.54. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
CEL-SCI Corporation Reports Third Quarter Fiscal 2021 Financial Results
From CEL-SCI Corporation
Via Business Wire
Analyzing CEL-SCI's Unusual Options Activity
On Tuesday, shares of CEL-SCI (AMEX:CVM) saw unusual options... 
Via Benzinga
Why CEL-SCI Shares Are Getting Hammered Today
CEL-SCI Corporation (NASDAQ:CVM) shares are trading lower b... 
Via Benzinga
Understanding CEL-SCI's Unusual Options Activity
CEL-SCI (AMEX:CVM) shares experienced unusual options activity on Monday. The stock price moved down to $7.68 following the option alert. Sentiment: NEUTRAL Option Type: TRADE... 
Via Benzinga
CEL-SCI Corporation (NYSE:CVM) Shareholder Notice: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 07/13/2021 -- CEL-SCI Corporation is under investigation concerning potential securities laws violations in connection with certain financial statements. 
Via SBWire
Unusual Options Activity Insight: CEL-SCI
Shares of CEL-SCI (AMEX:CVM) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $9.35. Sentiment: BEARISH Option Type:... 
Via Benzinga
Why CEL-SCI Stock Soared Today
The company attempted to clarify "confusion" related to its recent late-stage clinical results. 
Via The Motley Fool
CEL-SCI Corporation Issues Letter to Shareholders
From CEL-SCI Corporation
Via Business Wire
3 Biotechs to Avoid Like the Plague in July
Generally speaking, biotech is a pretty innovative industry -- with a few notable bad apples. 
Via The Motley Fool
Exposures COVID-19
Discussion of Results of CEL-SCI’s Phase 3 Trial Is Now Available
From CEL-SCI Corporation
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET on Friday, 43 companies set new 52-week lows. Points of Interest: Autohome (NYSE:ATHM) was the largest firm by market cap to set a new 52-week low... 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share. Cuentas Inc. (NASDAQ: CUEN... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
CEL-SCI to Conduct Investor Call Regarding Phase 3 Results Following Annual Shareholder Meeting on July 1, 2021
From CEL-SCI Corporation
Via Business Wire
51 Stocks Moving In Wednesday's Mid-Day Session
Gainers Cuentas Inc. (NASDAQ: CUEN) shares jumped 176.6% to $7.69. The stock spiked following a press release saying "WaveMax to Implement the World's First Shared Wifi6... 
Via Benzinga
Will All End Well for This Popular Reddit Biotech?
Everything went the wrong way for Cel-Sci. 
Via The Motley Fool
Mid-Afternoon Market Update: Nasdaq Gains 100 Points; New Senior Investment Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.49% to 34,266.49 while the NASDAQ rose 0.72% to 14,463.26. The S&P also rose, gaining 0.05% to 4,283.04. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
60 Biggest Movers From Yesterday
Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its... 
Via Benzinga
Nasdaq Hits Intraday Highs as Treasury Yields Retreat
The Dow Jones Industrial Average is 216 points lower at midday, erasing this morning's marginal gains amid growing pressures on energy and transportation stocks. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Crude Oil Down Over 1%; Intellia Therapeutics Shares Jump
Midway through trading Monday, the Dow traded down 0.52% to 34,253.86 while the NASDAQ rose 0.72% to 14,463.56. The S&P also fell, dropping 0.01% to 4,280.50. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
44 Stocks Moving In Monday's Mid-Day Session
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software... 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; Perion Network Boosts FY21 Outlook
Following the market opening Monday, the Dow traded down 0.30% to 34,329.01 while the NASDAQ rose 0.60% to 14,446.74. The S&P also rose, gaining 0.04% to 4,282.58. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
CEL-SCI's Immunotherapy Achieves Survival Benefit Of 14% Exceeding Pre-Defined 10% In Head & Cancer Patients
CEL-SCI Corporation (NYSE: CVM) has announced results from its Phase 3 study for its immunotherapy Multikine for advanced previously untreated squamous cell... 
Via Benzinga
CEL-SCI’s Multikine® Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) in the Group Receiving Surgery Plus Radiotherapy in a Landmark Head and Neck Cancer Phase 3 Study
From CEL-SCI Corporation
Via Business Wire
24 Stocks Moving in Monday's Pre-Market Session
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceuticals disclosed positive interim... 
Via Benzinga
CEL-SCI Corporation Invites Participants to Pre-Submit Questions for Annual Shareholder Meeting
From CEL-SCI Corporation
Via Business Wire
Cel-Sci Stock Shows Market Leadership With Jump To 81 RS Rating
Cel-Sci sees its Relative Strength Rating hit the 80-plus level. 
Via Investor's Business Daily
CEL-SCI Announces the Closing of $31.7 Million Bought Deal Offering
From CEL-SCI Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.